Concepedia
Vaccine · 2013 · 74 citations · 33 references
HistocompatibilityPrediction AnalysisHpv-16 E6MedicinePathogenesisImmunologyPathologyVirologyAntigen ProcessingHla TypingImmunotherapyMolecular DiagnosticsT CellCancer-associated Virus
33
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos et al. · The Journal of Pathology · 1999 · 9K citations
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
F. Xavier Bosch, M. Michele Manos, Núbia Muñóz et al. · JNCI Journal of the National Cancer Institute · 1995 · 3.4K citations
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
S N Boyer, David E. Wazer, Vimla Band · PubMed · 1996 · 931 citations
Proteasome, Pathology, Molecular Biology +18
Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
Tim Crook, Karen H. Vousden, John Tidy · Cell · 1991 · 513 citations
Molecular Biology, Cell Biology, Tumor Suppressor +7
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
Maaike E. Ressing, Alessandro Sette, Remco M.P. Brandt et al. · The Journal of Immunology · 1995 · 386 citations